Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease

We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.

Detalles Bibliográficos
Autores principales: Goggin, Kathryn P, Londeree, Jackson, Freeman, Alexandra F, Garro, Rouba, George, Roshan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Novel ID Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249262/
https://www.ncbi.nlm.nih.gov/pubmed/37305844
http://dx.doi.org/10.1093/ofid/ofad285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249262/
https://www.ncbi.nlm.nih.gov/pubmed/37305844
http://dx.doi.org/10.1093/ofid/ofad285

Ejemplares similares